Amwill Health Care Ltd

Amwill Health Care Ltd's Investment Committee has approved investments totaling ₹4 crore from internal accruals. The company will invest up to ₹3 crore in MO Alternates India Credit Excellence Fund – I (Category II AIF) and up to ₹1 crore in Government Securities and related products. These investments aim to support the company's financial growth, operational objectives, and long-term strategy. The disclosure is made in compliance with SEBI Listing Regulations, and no related party transactions are involved.

Amwill Health Care Ltd announced its audited financial results for the year ended March 31, 2026, along with the recommendation of a final dividend of ₹0.50 per equity share. The board confirmed no deviation in the utilization of IPO proceeds. The results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting on May 30, 2026. The company experienced a cybersecurity incident resulting in data loss, but most data was restored.

Amwill Health Care Ltd's Board of Directors approved the audited financial results for the half year and financial year ended March 31, 2026. The board recommended a final dividend of ₹0.50 per equity share of face value ₹10, i.e., @ 5% on the paid-up value per share, subject to shareholder approval at the AGM. The results and related information are available on the company's website.

Amwill Health Care Ltd has recommended a final dividend of ₹0.50 per equity share with a face value of ₹10 each, which is 5% on the paid-up value per share, for the financial year ended March 31, 2026. This recommendation is subject to shareholder approval at the upcoming Annual General Meeting. The decision was made during the Board of Directors meeting held on May 30, 2026, where the audited financial results for the same period were also approved.

Amwill Health Care Ltd approved the audited financial results for the half year and financial year ended March 31, 2026, as per Regulation 30 of SEBI Listing Regulations. The board also recommended a final dividend of ₹0.50 per equity share, subject to shareholder approval at the AGM. The results and auditor's report, issued by M/s SKLR & Co. LLP, are available on the company's website. The company experienced a cybersecurity incident on February 18, 2026, resulting in data loss, but most data was recovered.

Amwill Health Care Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the half-year and financial year ended March 31, 2026. The board will also consider recommending a final dividend, if any, on the company's equity shares for the same financial year, subject to shareholder approval at the Annual General Meeting. The trading window for dealing in the company's securities remains closed and will reopen 48 hours after the announcement of the audited financial results.

Amwill Health Care Ltd. has updated and restored its IT systems and Unpublished Price Sensitive Information (UPSI) entries following a security incident on February 18, 2026. The company took immediate steps to contain and remediate the impact of the incident, isolating the network and re-entering affected account data. A PCS certificate from Mr. Saurabh Talwar, PCS Delhi, confirms the completion of all SDD entries. The maintenance, accuracy, and completeness of UPSI entries are the responsibility of the company's management.

Amwill Health Care Ltd has announced the closure of the trading window for all Designated Persons, their immediate relatives, and other Insiders as per the Insider Trading Policy. The closure will be effective from April 1st, 2026, till 48 hours after the announcement of the Audited Financial Results for the Half Year and Financial Year ending March 31st, 2026. The date of the Board meeting to consider the aforesaid financial results will be intimated separately. The PAN of Designated Persons of the Company will be frozen by National Securities Depository Limited for trading in the Equity Shares of the Company during the said trading window closure period.

Amwill Health Care Ltd. has experienced a cyber security incident that has impacted all account-related data from September 30, 2025 onwards. The Company assures that data required for compliance with the Companies Act and Stock Exchange regulations remains secure and has not been affected. Upon detection, the Company's technical team, along with specialized cybersecurity experts and management, responded promptly, isolating the affected systems and initiating a detailed investigation. Appropriate containment, remediation, and recovery actions are being taken. Further updates will be shared as necessary.

Amwill Health Care Ltd has announced the re-appointment of SPR & Co, Chartered Accountants as the Internal Auditor for the financial year 2025-26. The decision was made at a Board of Directors meeting, following the recommendation of the Audit Committee. SPR & Co is a renowned management consulting firm known for its commitment to original thinking and delivering meaningful insights. The firm has a global footprint and a team of over 400 professionals with diverse expertise.